Rodger Tiedemann
doctorMale0.0Global Dominance: 0.00%
Dr. Rodger Tiedemann is a haematologist at Auckland Hospital and an associate professor of medicine at the University of Auckland, who advocates for the funding of daratumumab, a drug that significantly improves survival rates for patients with multiple myeloma and AL amyloidosis, highlighting New Zealand's lag in providing such essential treatments.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Dr. Rodger Tiedemann is an associate professor at the University of Auckland who discusses the effectiveness of CAR T-cell therapy.
Inside Kiwi photographer Jason Oxenham’s CAR T-cell cancer comebackThe New Zealand Herald – country’s largest newspaper, est. 1863·
New Zealand· 2025-12-20
New Zealand· 2025-12-20
Dr Rodger Tiedemann says drugs like lenalidomide can extend life by 5-10 years.
Old drugs, new tricks: From aspirin to statins – how repurposed meds can help fight cancersThe New Zealand Herald – country’s largest newspaper, est. 1863·New Zealand· 2025-05-11
New Zealand· 2025-05-11
Dr. Rodger Tiedemann stated that patients with multiple myeloma lived longer on daratumumab.
Daratumumab: Rotorua cancer survivor Tove Jensen-Munroe calls for drug fundingThe New Zealand Herald – country’s largest newspaper, est. 1863·New Zealand· 2025-03-17
New Zealand· 2025-03-17
